Pluripotent stem cells used for regenrative medicine risks. They can develop mutations that favor the production of cancer cells

It should be crucial to check pluripotent cell lines (embryonic and iPS cells) before clinical testing before their use in regenerative medicine The production of pluripotent stem cells, from which virtually all types of cells can be obtained, may be of great use for the...

The future of iPS – induced pluripotent stem cells. New finding increases tremendously their potential for clinical use

Cells now can be obtained from anonymous donors, however, and stored in a cell bank, the costs would be reduced significantly, and their potential for clinical use would increase tremendously A recent article published in Nature discussed some specific aspects regarding the...

New clinical celular trial for treatment of Parkinson’s disease injecting stemcells in the patient brain

A first step to a Parkinson treatment with stem cells. The first clinical trial conducted in China (see HERE) to treat Parkinson’s disease and age-related macular degeneration and the second most common neurodegenerative disorder is to be launched shortly. In the next few...

The biological status of the early human embryo. When does human life begins?

“Those who argue that that embryo can be destroyed with impunity will have to prove that this newly created life is not human. And no-one, to the best of our knowledge, has yet been able to do so.” Introduction In order to determine the nature of the human embryo, we need to know...

Ten years since the discovery of iPS cells. The current state of their clinical application

  Rev Clin Esp. 2017 Jan – Feb;217(1):30-34. doi: 10.1016/j.rce.2016.08.003. Epub 2016 Oct 5. Justo Aznar Ph.D. MD Julio Tudela Pharm Ph.D. Institute of Life Science – Bioethics Observatory Catholic University of Valencia – Spain iPS cells current clinical...

Stem cell research. The two sides of the coin

Science facing market The “heads” of stem cell research Stem cells today represent a great hope for the future of regenerative medicine due to their ability to differentiate into cell lines of almost any tissue, making them a promising therapeutic option for many...

Cerebral organoids produced from embryonic stem cells

A group of researchers in La Jolla, California, have produced three-dimensional  cerebral organoids (“mini-brains”) from human embryonic stem cells, later comparing the functionality of the tissue produced with samples of brain tissue from human foetuses with the same...

Clinical trials using embryonic stem cells authorised in the United States

Clinical trials using embryonic stem cells which, as we know, requires the destruction of human embryos, is approved The North American FDA has given its approval to the Californian company Asterias Biotherapeutics to begin a clinical trial at the beginning of 2015. The aim of...

Is it morally licit to use cell lines obtained from currently stored embryonic stem cells?

One of our colleagues, a doctor in Molecular Biology who is currently conducting post-doctoral research in the United States, mentioned to us that he had “recently discovered that the cells with which he was working come from human embryos, the famous HEK-293 cells”....